Scaling Network Medicine with LLMs for Combinatorial Drug Repurposing in ER+ Breast Cancer
Ahmed Abdeen Hamed, Tamer E. Fandy, Luis Mateus Rocha
The paper develops an LLM-driven framework for drug repurposing in ER+ breast cancer, identifying 166 significant drug combinations using pathway analysis and consensus networks.
bioRxiv · Sep 20, 2026 · PreprintBioinformatics